McDermott Advises Brightflow on Its Series A Fundraising
September 19, 2024
September 19, 2024
CHICAGO, Illinois, Sept. 19 -- McDermott Will and Emery, a law firm, issued the following news release:
McDermott Will & Emery has advised Brightflow SAS, a privately held pioneer in the field of long-term percutaneous mechanical circulatory support to treat end-stage heart failure patients, on its Serie A fundraising.
The EUR 16.5 million round was led by new investors VIVES Partners (Belgium), Majycc Innovation Sante - UI Investissement (France), BNP Paribas Devel . . .
McDermott Will & Emery has advised Brightflow SAS, a privately held pioneer in the field of long-term percutaneous mechanical circulatory support to treat end-stage heart failure patients, on its Serie A fundraising.
The EUR 16.5 million round was led by new investors VIVES Partners (Belgium), Majycc Innovation Sante - UI Investissement (France), BNP Paribas Devel . . .